Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Canada / NCT07025499
Starting soon Not applicable

Piloting and Evaluation of a Group Intervention for People With Psychosis Designed to Boost Access and Usage of ICT

NCT07025499 · tracked via the Priya Life Science Canada tracker
Sponsor
McMaster University
Phase
Not applicable
Started
2025-07-15
Last updated
2025-06-17

Condition(s) studied

Serious Mental Illness

Investigational drug(s) / intervention(s)

Group ICT Intervention

Group ICT Intervention: Participants will be given access to a tablet. With this technology, participants will be invited to set personal goals related to using this technology to foster social connection and community participation. Participants will attend a group led by two occupational therapy students and an occupational therapist focused on digital literacy and how to use technology to meet their goals. In the group, participants will learn how to use their device and how to safely access various online resources and tools to support their recovery. Participants will keep their provided devices upon conclusion of the group sessions. Participants will complete quantitative outcome measures at the start and end of the group intervention. Participants will be invited to attend a semi-structured interview one month after the completion of the group about their experiences with the program.

Study summary

Participants will be given access to a tablet. With this technology, participants will be invited to set personal goals related to using this technology to foster social connection and community participation. Participants will attend a group led by two occupational therapy students and an occupational therapist focused on digital literacy and how to use technology to meet their goals. In the group, participants will learn how to use their device and how to safely access various online resources and tools to support their recovery. Participants will keep their provided devices upon conclusion of the group sessions. Participants will complete quantitative outcome measures at the start and end of the group intervention. Participants will be invited to attend a semi-structured interview one month after the completion of the group about their experiences with the program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Specific inclusion criteria for participants in this study will include being diagnosed with a psychotic disorder, living in the Hamilton area, ability to communicate in English, and having more than one episode of psychosis. Every effort will be made to recruit participants from study with HiREB approvals #17367 and #18549, as indicated in that study's previous consent form, for those that have consented to be contacted for future research. Exclusion Criteria: * Exclusion criteria include currently experiencing an acute psychotic episode or medical condition that would render them incapable of meaningfully participating in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. Joseph's Healthcare Hamilton Hamilton Ontario

More McMaster University trials in Canada

Sacral Neuromodulation as Treatment for Fecal Incontinence Recruiting
PeerOnCall: Implementing and Evaluating App-Based Peer Support in Canadian Fire Services Starting soon
The Effect of Chiropractic Care on Opioid Use for Chronic Spinal Pain: A Feasibility Study Starting soon
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease Recruiting
Investigating Serotonin Signalling in IBD Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07025499 on ClinicalTrials.gov ↗ ← All trials in Canada